Although we have not quantified pERKs labelling at 28 days in the present study, previous studies from our group in the monoarthritis model showed that anxiety-like behaviors were also present at this time point and that inhibition of ERK1/2 activation in the LC prevented the development of these behaviors at the same time point [12]. The gene discussed is MAPK3; the disease is Anxiety.